Novo Chief’s Remuneration Climbed 7.5% Last Year: Annual Report

Novo Nordisk A/S Chief Executive Officer Lars Sorensen’s remuneration climbed 7.5% last year, the 2012 annual report of the world’s biggest insulin maker shows.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.